These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hormone therapy and breast cancer risk: trumping fear with facts. Kaunitz AM Menopause; 2006; 13(2):160-3. PubMed ID: 16645526 [No Abstract] [Full Text] [Related]
24. Bioidentical hormones. Well E Adv Nurse Pract; 2009 Sep; 17(9):37-8, 40-1. PubMed ID: 20000171 [No Abstract] [Full Text] [Related]
25. Few Alternatives As HRT 'Fountain of Youth' Runs Dry. Schultz J J Natl Cancer Inst; 2004 Aug; 96(16):1202-3. PubMed ID: 15316054 [No Abstract] [Full Text] [Related]
26. [Hormone replacement therapy of menopause. When to begin? When to stop?]. Tabaste JL Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518 [No Abstract] [Full Text] [Related]
27. The 'timing hypothesis' for estrogen therapy in menopausal symptom management. Manson JE Womens Health (Lond); 2015 Jul; 11(4):437-40. PubMed ID: 26237097 [No Abstract] [Full Text] [Related]
28. [Hormone therapy and menopause]. Heutling D; Lehnert H Dtsch Med Wochenschr; 2005 Apr; 130(13):829-34. PubMed ID: 15789305 [No Abstract] [Full Text] [Related]
30. [Hormone replacement therapy for prevention in postmenopausal women: the end of controversy?]. Balasch J Med Clin (Barc); 2002 Oct; 119(11):416-7. PubMed ID: 12381276 [No Abstract] [Full Text] [Related]
31. Health risks after cessation of postmenopausal hormone therapy. Pines A; Sturdee D; Birkhäuser M; Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782 [No Abstract] [Full Text] [Related]
32. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy. Grant EC J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925 [No Abstract] [Full Text] [Related]
33. [Hormone replacement therapy in menopause: continue or stop the prescription after 10 years? There are reasons to continue hormone replacement therapy longer than 10 years]. Rozenbaum H Gynecol Obstet Fertil; 2002 Sep; 30(9):723-32. PubMed ID: 12448371 [No Abstract] [Full Text] [Related]
35. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer]. Lopes P J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684 [No Abstract] [Full Text] [Related]
36. Breast cancer and hormone-replacement therapy: the Million Women Study. Yong SP Lancet; 2003 Oct; 362(9392):1331; author reply 1332. PubMed ID: 14575992 [No Abstract] [Full Text] [Related]
37. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Kuller LH J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556 [No Abstract] [Full Text] [Related]
38. [Hormone therapy after menopause – new knowledge about long-term risks]. Gjelsvik B Tidsskr Nor Laegeforen; 2018 Jan; 138(1):. PubMed ID: 29313626 [No Abstract] [Full Text] [Related]
39. Individualizing hormone-therapy according to cardiovascular risk. Shoupe D Minerva Med; 2012 Oct; 103(5):343-52. PubMed ID: 23042369 [TBL] [Abstract][Full Text] [Related]